Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Login
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press/Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
Translational biomarkers of the DREAM study (a phase 2 trial of durvalumab with first line chemotherapy in mesothelioma with a safety run in
Nowak, Anna
(Investigator 01)
Lesterhuis, Willem
(Investigator 02)
Cook, Alistair
(Investigator 03)
Office of DVC Research
School of Biomedical Sciences
UWA Centre for Child Health Research (affiliated with the The Kids Research Institute Australia)
Overview
Project Details
Status
Finished
Effective start/end date
1/07/19
→
30/06/20
Funding
AstraZeneca:
A$155,100.00
View all
View less